Multiple Ascending Dose Trial of BYK324677 in Healthy Volunteers

Summary

This monocenter trial is conducted to obtain first data on safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) after multiple ascending doses of BYK324677 in humans. In addition, the trial should provide preliminary information on a possible influence of sex, food intake, and posology (once or twice daily administration of BYK324677) to support the further planning of the drug development programme.

Timeline

Start

2011-06

Primary completion

2011-09

Completion

2011-11

Drugs

Indications